| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/09/1997 | CA2224799A1 A human edg-2 receptor homolog |
| 01/08/1997 | EP0752249A2 Use of an angiotensin II antagonist and a benzofurane derivative having antiarithmic activity for the manufacture of a medicament for the treatment of cardiovascular disorders |
| 01/08/1997 | EP0752248A1 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| 01/08/1997 | EP0752243A2 Container filled with infusion liquids |
| 01/08/1997 | EP0751782A1 Methods for altering fertility |
| 01/08/1997 | EP0751709A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 01/08/1997 | CN1139881A Aqueous topical compositions |
| 01/07/1997 | US5591892 Allosteric modifiers of hemoglobin |
| 01/07/1997 | US5591860 Retroviral protease inhibiting compounds |
| 01/07/1997 | US5591774 Method of treating wrinkles using malic acid |
| 01/07/1997 | US5591770 Calanolide and related antiretroviral compounds, compositions, and uses thereof |
| 01/07/1997 | US5591768 Methods for treating circadian rhythm phase disturbances |
| 01/07/1997 | US5591740 Use of debromohymenialdisine for treating osteoarthritis |
| 01/07/1997 | US5591710 Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute |
| 01/07/1997 | US5591441 Composition for nonspecific cellular immune stimulation |
| 01/07/1997 | CA2038097C Method and composition for coiontophoresis |
| 01/07/1997 | CA2029050C Sustained release compositions for treating periodontal disease |
| 01/03/1997 | WO1997000088A2 Rotavirus enterotoxin nsp4 and methods of using same |
| 01/03/1997 | WO1997000073A1 Novel use for pyrrole derivatives |
| 01/03/1997 | WO1997000069A1 Melatonin agonists for treating benign prostatic hyperplasia |
| 01/03/1997 | WO1996037201A3 METHODS AND COMPOSITIONS FOR INHIBITING 5α-REDUCTASE ACTIVITY |
| 01/03/1997 | WO1996030009A3 Compositions for treatment of photodamaged skin comprising an rar-alpha antagonist and a multi-selective retinoid |
| 01/03/1997 | CA2224697A1 Rotavirus enterotoxin nsp4 and methods of using same |
| 01/03/1997 | CA2224649A1 Melatonin agonists for treating benign prostatic hyperplasia |
| 01/03/1997 | CA2221027A1 Novel use for pyrrole derivatives |
| 01/02/1997 | EP0750628A1 Fibroblast growth factor-10 |
| 01/02/1997 | EP0750515A1 Low molecular weight hyaluronic acid with peptide or protein |
| 01/02/1997 | EP0750512A1 A medical use of matrix metalloproteinase inhibitors for inhibiting tissue contraction |
| 01/02/1997 | EP0750510A1 Skin treatment composition |
| 01/02/1997 | EP0750507A1 PROTEASOME REGULATION OF NF-$g(k)B ACTIVITY |
| 01/02/1997 | EP0750505A1 Immunotherapy of cancer with allogeneic lymphocytes |
| 01/02/1997 | EP0750498A1 Use of antagonists of egf or tgf-alpha for the treatment and prophylaxis of acne |
| 12/31/1996 | US5589513 Pharmaceutical composition and process for the preparation thereof |
| 12/31/1996 | US5589508 Use of an emulsion to prepare an intravensously administered medicament for treating skin diseases |
| 12/31/1996 | US5589505 Method of treating wrinkles using quinic acid or quinolactone |
| 12/31/1996 | US5589475 Benzodiazepine treatment |
| 12/31/1996 | US5589192 Gel pharmaceutical formulation for local anesthesia |
| 12/31/1996 | US5589173 Anticoagulants |
| 12/31/1996 | US5589156 Prilocaine and hydrofluourocarbon aerosol preparations |
| 12/31/1996 | US5588422 Methods and pharmaceutical compositions for enhanced cardiopulmonary resuscitation |
| 12/27/1996 | WO1996041818A1 Chitin hydrogels, methods of their production and use |
| 12/27/1996 | WO1996041807A1 Rapamycin derivatives |
| 12/27/1996 | WO1996041645A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations |
| 12/27/1996 | WO1996041639A1 Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells |
| 12/27/1996 | WO1996041635A1 Pharmaceutical compositions containing a diclofenac salt and thiocolchicoside |
| 12/27/1996 | WO1996041633A1 Methods of treating cold and allergic rhinitis |
| 12/27/1996 | WO1996041626A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 12/27/1996 | WO1996041625A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor |
| 12/27/1996 | WO1996041624A1 TNF-α CONVERTING ENZYME |
| 12/27/1996 | WO1996041620A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
| 12/27/1996 | WO1996041616A1 Formulations and methods for providing prolonged local anesthesia |
| 12/27/1996 | WO1996041523A1 Fgf9 as a specific ligand for fgfr3 |
| 12/27/1996 | WO1996037226A3 Combinations for the treatment of parkinsonism containing selective nmda antagonists |
| 12/27/1996 | EP0750037A2 TNF-convertase and method measuring inhibition of TNF convertase |
| 12/27/1996 | EP0749752A1 Use of specific RXR receptor ligands |
| 12/27/1996 | EP0749751A2 Pharmaceutical composition for use in tteatment of diabetes |
| 12/27/1996 | EP0749415A1 Benzamide analogs, useful as parp (adp-ribosyltransferase, adprt) dna repair enzyme inhibitors |
| 12/27/1996 | EP0749314A1 Method for treating and inhibiting gastric and duodenal ulcers |
| 12/27/1996 | EP0749309A1 Treatment of obsessive-compulsive disorders with 5-ht 2? antagonists |
| 12/27/1996 | CA2349017A1 Formulations and methods for providing prolonged local anesthesia |
| 12/27/1996 | CA2224563A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations |
| 12/27/1996 | CA2224517A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 12/27/1996 | CA2224379A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor |
| 12/27/1996 | CA2224253A1 Chitin hydrogels, methods of their production and use |
| 12/27/1996 | CA2224229A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
| 12/25/1996 | CN1138572A Application of Ubimec medicinal compsn. or containing ubimec for treatment virus hepatitis |
| 12/24/1996 | US5587480 Treating hiv and hepatitis virus infections |
| 12/24/1996 | US5587306 Dna sequences |
| 12/24/1996 | US5587161 Prodrugs for antibody directed enzyme prodrug therapy |
| 12/24/1996 | CA2030174C Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates |
| 12/20/1996 | CA2179426A1 Use of ligands specific to rxr receptors |
| 12/19/1996 | WO1996040895A1 Method for identifying alzheimer's disease therapeutics using transgenic animal models |
| 12/19/1996 | WO1996040894A1 Treatment of insulin resistance |
| 12/19/1996 | WO1996040885A2 β-SECRETASE, ANTIBODIES TO β-SECRETASE, AND ASSAYS FOR DETECTING β-SECRETASE INHIBITION |
| 12/19/1996 | WO1996040725A1 Phosphonic acid-based cationic lipids |
| 12/19/1996 | WO1996040721A1 A cytotoxicity-based genetic selection system (toxsel) |
| 12/19/1996 | WO1996040657A1 Inhibitors of phospholipase a¿2? |
| 12/19/1996 | WO1996040633A1 Small molecule inhibitors of rotamase enzyme activity |
| 12/19/1996 | WO1996040620A1 Chalcone retinoids and methods of use of same |
| 12/19/1996 | WO1996040285A1 Novel targeted compositions for diagnostic and therapeutic use |
| 12/19/1996 | WO1996040258A2 Spironolactone and angiotensin ii antagonist combination therapy for treatment of congestive heart failure |
| 12/19/1996 | WO1996040257A1 Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy for treatment of congestive heart failure |
| 12/19/1996 | WO1996040256A1 Method to treat cardiofibrosis with a combination of an angiotensin ii antagonist and spironolactone |
| 12/19/1996 | WO1996040255A2 Method to treat cardiofibrosis with a combination therapy of an angiotensin ii antagonist and an epoxy-steroidal aldosterone antagonist |
| 12/19/1996 | WO1996040250A2 Platelet-specific chimeric immunoglobulin and methods of use therefor |
| 12/19/1996 | WO1996040246A1 Treatment of t cell mediated autoimmune disorders |
| 12/19/1996 | WO1996040245A1 Improved delivery of diagnostic and therapeutic agents to a target site |
| 12/19/1996 | WO1996040223A1 Oxidant scavengers |
| 12/19/1996 | WO1996040210A1 Antibody and antibody fragments for inhibiting the growth of tumors |
| 12/19/1996 | WO1996040199A1 Methods of inhibiting phagocytosis |
| 12/19/1996 | WO1996040196A1 Appetite regulating compositions |
| 12/19/1996 | WO1996040191A1 The treatment of hiv and other viral infections using combinatory therapy |
| 12/19/1996 | WO1996040174A1 Supplemented and unsupplemented tissue sealants, methods of their production and use |
| 12/19/1996 | WO1996040171A1 Intrauterine chemical necrosing method and composition |
| 12/19/1996 | WO1996040168A2 Use of hydroxyethyl starch to prevent post surgical adhesion and as an intracavity carrier device |
| 12/19/1996 | WO1996040167A1 Augmented atp production |
| 12/19/1996 | WO1996040165A1 Methods of reducing toxicity of chemotherapeutic and antiviral agents with acylated pyrimidine nucleosides |
| 12/19/1996 | WO1996040150A1 Treatment and prevention of prostatic disease |
| 12/19/1996 | WO1996040147A1 Use of debromohymenialdisine and related compounds for treating osteoarthritis |
| 12/19/1996 | WO1996040140A1 Inhibitors of rotamase enzyme activity |